Kai Liu

机构：United Therapeutics (United States), Drug Discovery Laboratory (Norway) · ORCID：0000-0001-7252-5939

发表论文 64 篇 · 总被引 450 次 · h-index 12

代表论文

• Benchmarking AI Models for In Silico Gene Perturbation of Cells (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 22)
• BVTED: A Specialized Bilingual (Chinese–English) Dataset for Vulnerability Triple Extraction Tasks (2024 · Applied Sciences · 被引 2)
• Enhanced Prototypical Network for Few-Shot Named Entity Recognition (2024 · Communications in computer and information science · 被引 2)
• Ontology-Based APT Attack Detection and Defense Countermeasures (2022 · 被引 2)
• Learning the All-Atom Equilibrium Distribution of Biomolecular Interactions at Scale (2026 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• VPS34 inhibition as a host-targeting anti-coronaviral strategy: Rational design of YBM with optimized pharmacokinetic parameters (2025 · Acta Pharmaceutica Sinica B · 被引 1)